299 related articles for article (PubMed ID: 28838453)
1. Cholestasis After Pediatric Liver Transplantation-Recurrence of a Progressive Familial Intrahepatic Cholestasis Phenotype as a Rare Differential Diagnosis: A Case Report.
Prusinskas B; Kathemann S; Pilic D; Hegen B; Küster P; Keitel V; Häussinger D; Büscher R; Baba HA; Hoyer PF; Lainka E
Transplant Proc; 2017 Sep; 49(7):1628-1633. PubMed ID: 28838453
[TBL] [Abstract][Full Text] [Related]
2. High affinity anti-BSEP antibodies after liver transplantation for PFIC-2 - Successful treatment with immunoadsorption and B-cell depletion.
Kubitz R; Dröge C; Kluge S; Stindt J; Stross C; Häussinger D; Flechtenmacher C; Wenning D; Teufel U; Schmitt CP; Engelmann G
Pediatr Transplant; 2016 Nov; 20(7):987-993. PubMed ID: 27368585
[TBL] [Abstract][Full Text] [Related]
3. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2.
Maggiore G; Gonzales E; Sciveres M; Redon MJ; Grosse B; Stieger B; Davit-Spraul A; Fabre M; Jacquemin E
J Hepatol; 2010 Nov; 53(5):981-6. PubMed ID: 20800306
[TBL] [Abstract][Full Text] [Related]
4. Alloimmunity and Cholestasis After Liver Transplantation in Children With Progressive Familial Intrahepatic Cholestasis.
Krebs-Schmitt D; Briem-Richter A; Brinkert F; Keitel V; Pukite I; Lenhartz H; Fischer L; Grabhorn E
J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):169-174. PubMed ID: 30664572
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of Progressive Familial Intrahepatic Cholestasis Type 2 Phenotype After Living-donor Liver Transplantation: A Case Report.
Masahata K; Uehara S; Ibuka S; Nakahata K; Hasegawa Y; Kondou H; Kubitz R; Ueno T
Transplant Proc; 2016 Nov; 48(9):3156-3162. PubMed ID: 27932171
[TBL] [Abstract][Full Text] [Related]
6. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis.
Keitel V; Burdelski M; Vojnisek Z; Schmitt L; Häussinger D; Kubitz R
Hepatology; 2009 Aug; 50(2):510-7. PubMed ID: 19642168
[TBL] [Abstract][Full Text] [Related]
7. Rituximab as therapy for the recurrence of bile salt export pump deficiency after liver transplantation.
Lin HC; Alvarez L; Laroche G; Melin-Aldana H; Pfeifer K; Schwarz K; Whitington PF; Alonso EM; Ekong UD
Liver Transpl; 2013 Dec; 19(12):1403-10. PubMed ID: 24115678
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
[TBL] [Abstract][Full Text] [Related]
9. Bile salt export pump-reactive antibodies form a polyclonal, multi-inhibitory response in antibody-induced bile salt export pump deficiency.
Stindt J; Kluge S; Dröge C; Keitel V; Stross C; Baumann U; Brinkert F; Dhawan A; Engelmann G; Ganschow R; Gerner P; Grabhorn E; Knisely AS; Noli KA; Pukite I; Shepherd RW; Ueno T; Schmitt L; Wiek C; Hanenberg H; Häussinger D; Kubitz R
Hepatology; 2016 Feb; 63(2):524-37. PubMed ID: 26516723
[TBL] [Abstract][Full Text] [Related]
10. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
Davit-Spraul A; Fabre M; Branchereau S; Baussan C; Gonzales E; Stieger B; Bernard O; Jacquemin E
Hepatology; 2010 May; 51(5):1645-55. PubMed ID: 20232290
[TBL] [Abstract][Full Text] [Related]
11. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.
Ellinger P; Stindt J; Dröge C; Sattler K; Stross C; Kluge S; Herebian D; Smits SHJ; Burdelski M; Schulz-Jürgensen S; Ballauff A; Schulte Am Esch J; Mayatepek E; Häussinger D; Kubitz R; Schmitt L
World J Gastroenterol; 2017 Aug; 23(29):5295-5303. PubMed ID: 28839429
[TBL] [Abstract][Full Text] [Related]
12. Iterative antibody-induced bile salt export pump deficiency after successive liver transplantations successfully treated with plasmapheresis and rituximab.
Wischlen E; Laverdure N; Erard D; Rohmer B; Boillot O; Dubois R; Lachaux A; Collardeau-Frachon S; Hervieu V; Dumortier J
Clin Res Hepatol Gastroenterol; 2023 May; 47(6):102139. PubMed ID: 37187258
[TBL] [Abstract][Full Text] [Related]
13. Progressive familial intrahepatic cholestasis.
Jacquemin E
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
[TBL] [Abstract][Full Text] [Related]
15. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
[TBL] [Abstract][Full Text] [Related]
16. Late-Onset Drug-Induced Cholestasis in a Living-Related Liver Transplant Donor With Progressive Familial Intrahepatic Cholestasis.
Harmancı Ö; Ensaroğlu F; Özçay F; Öcal S; Korkmaz M; Özdemir BH; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():107-9. PubMed ID: 26640927
[TBL] [Abstract][Full Text] [Related]
17. Clinical phenotype and molecular analysis of a homozygous ABCB11 mutation responsible for progressive infantile cholestasis.
Imagawa K; Hayashi H; Sabu Y; Tanikawa K; Fujishiro J; Kajikawa D; Wada H; Kudo T; Kage M; Kusuhara H; Sumazaki R
J Hum Genet; 2018 May; 63(5):569-577. PubMed ID: 29507376
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic haematopoietic stem cell transplantation eliminates alloreactive inhibitory antibodies after liver transplantation for bile salt export pump deficiency.
Brinkert F; Pukite I; Krebs-Schmitt D; Briem-Richter A; Stindt J; Häussinger D; Keitel V; Müller I; Grabhorn E
J Hepatol; 2018 Oct; 69(4):961-965. PubMed ID: 29935200
[TBL] [Abstract][Full Text] [Related]
19. Cell-based BSEP trans-inhibition: A novel, non-invasive test for diagnosis of antibody-induced BSEP deficiency.
Stindt J; Dröge C; Lainka E; Kathemann S; Pfister ED; Baumann U; Stalke A; Grabhorn E; Shagrani MA; Mozer-Glassberg Y; Hartley J; Wammers M; Klindt C; Philippski P; Liebe R; Herebian D; Mayatepek E; Berg T; Schmidt-Choudhury A; Wiek C; Hanenberg H; Luedde T; Keitel V
JHEP Rep; 2023 Jul; 5(7):100690. PubMed ID: 37425215
[TBL] [Abstract][Full Text] [Related]
20. Successful Treatment with Rituximab and Immunoadsorption for an Auto-Antibody Induced Bile Salt Export Pump Deficiency in a Liver Transplanted Patient.
Quintero J; Juamperez J; Gonzales E; Julio E; Mercadal-Hally M; Collado-Hilly M; Marín-Sánchez A; Charco R
Pediatr Gastroenterol Hepatol Nutr; 2020 Mar; 23(2):174-179. PubMed ID: 32206630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
